Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 72

Sort by

Sort Order Select

Journal Articles

Management of Delayed Elimination of High-Dose Methotrexate in Community Oncology Practices Can Mitigate Its Effect on Length of Hospital Stay, Treatment Dose-Density, Acute Kidney Injury, Dialysis, and Death

Scott Howard, MD, McKeon Tad Harry, PhD, Sfondouris John, PhD, Suresh Marada, PhD, Nicholas Napier, BS

Blood (2019) 134 (Supplement_1): 5889.

https://doi.org/10.1182/blood-2019-132098

Published: 2019

Journal Articles

Single Arm, Single Centre Prospective Study to Assess the Effect of Therapeutic Drug Monitoring (TDM) Based Dosage Adjustment of Posaconazole on the Incidence of Invasive Fungal Infections (IFIs) in AML Patients on Induction Chemotherapy on Posaconazole Prophylaxis

Manju Sengar, MD DM, Mounika Boppana, MD DM, Hasmukh Jain, MD DM, Vikram Gota, MD, Bhausaheb Bagal, MD DM, Anant Gokarn, MD, Murari Gujrar, MD, Madhavi Ambotkar, MD

Blood (2019) 134 (Supplement_1): 2600.

https://doi.org/10.1182/blood-2019-129948

Published: 2019

Journal Articles

Pharmacokinetic and Pharmacogenetic Analysis of Bosutinib in Japanese Patients with Chronic-Phase Chronic Myeloid Leukemia

Akiko Mita, MD, Maiko Abumiya, PhD, Saori Takahashi, Ms, Yoshihiro Kameoka, MD PhD, Masatomo Miura, PhD, Naoto Takahashi, MD

Blood (2018) 132 (Supplement 1): 4271.

https://doi.org/10.1182/blood-2018-99-111905

Published: 2018

Journal Articles

Pharmacist Interventions on Outpatient Leukemia Patients Improve Safety

Madeline Waldron, PharmD, Caitlin Siebenaller, PharmD, Marc Earl, PharmD, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MDMS, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Barb Tripp, CNS, Brian P. Hobbs, PhD, Sudipto Mukherjee, MD PhD MPH, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 712.

https://doi.org/10.1182/blood-2018-99-110029

Published: 2018

Journal Articles

Drug Monitoring of Asparaginase Activity to Detect Silent Inactivation in Pediatric Acute Lymphoblastic Leukemia Patients Receiving Peg-Asparaginase

Van Thu Huynh, MD, Alexa Love, BA, Mary English, CPNP, Carol Hwang Lin, MD

Blood (2018) 132 (Supplement 1): 3968.

https://doi.org/10.1182/blood-2018-99-117165

Published: 2018

Journal Articles

Cost-Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Patients with Chronic Myeloid Leukemia

Kibum Kim, PhD, Gwendolyn A. McMillin, PhD, Philip S. Bernard, MD, Srinivas K. Tantravahi, MBBS, Brandon Walker, MS, Robert L Schmidt, MD PhD MBA

Blood (2018) 132 (Supplement 1): 3547.

https://doi.org/10.1182/blood-2018-99-120263

Published: 2018

Journal Articles

Interest of Dosing of Ibrutinib in B-Cell Lymphoid Malignancies: Data from a Real-Life, Phase 4 Study

Anne Calleja, Sandra De Barros, Camille Vinson, PharmD, Caroline Protin, MD, Lucie Oberic, MD, Fanny Gallais, Melanie White-koning, Etienne Chatelut, Christian Recher, MD PhD, Sarah Cadot, PhD, Anne Quillet Mary, PhD, Loic Ysebaert, MD PhD, Fabien Despas, PharmD, PhD

Blood (2018) 132 (Supplement 1): 3960.

https://doi.org/10.1182/blood-2018-99-116532

Published: 2018

Journal Articles

Isavuconazole (ISAV) As Primary Anti-Fungal Prophylaxis in Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective Study

Blood (2018) 132 (Supplement 1): 2674.

https://doi.org/10.1182/blood-2018-99-111727

Published: 2018

Journal Articles

Impact of a Pharmacist Driven Anti-Xa Level Monitoring Protocol on Therapeutic Drug Monitoring Practice Patterns

Muhammad Effendi, PharmD, Martha Stutsky, PharmD, Caleigh A. Curran, PharmD, Kent A. Owusu, PharmD, Alfred Ian Lee, MD PhD

Blood (2018) 132 (Supplement 1): 2284.

https://doi.org/10.1182/blood-2018-99-119379

Published: 2018

Journal Articles

Outcomes of Patients with Pre-Existing Invasive Fungal Disease Undergoing Allogeneic Haematopoietic Stem Cell Transplantation — 5 Years Single Centre Experience

Varun Mehra, MRCP, FRCPath, Eleanor Barnwell, Ute Boczek, Stefanie Widya, Kavita Raj, MD PhD, Hugues De Lavallade, Donal McLornan, Victoria Potter, Carmel Rice, FRACP, FRCPA, MBBS, Christina Lim, Michelle Kenyon, Alessandra Bisquera, Judith Marsh, MD, M. Mansour Ceesay, MDFRCP,FRCPath, Antonio Pagliuca, MD, Ghulam Mufti, DM, FRCP, FRCPath

Blood (2017) 130 (Supplement 1): 3216.

https://doi.org/10.1182/blood.V130.Suppl_1.3216.3216

Published: 2017

Journal Articles

The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients Treated for Venous Thromboembolism

Scott D. Berkowitz, MD, Jeffrey I Weitz, MD FRCPC, FACP, Stephan Schmidt, Keith A A Fox, MBBS, Dirk Garmann, Dagmar Kubitza, Wolfgang Mueck, Gary Peters, MD, Isabel Reinecke, Alexander Solms, Theodore E Spiro, MD, Xiaoyu Yan, PhD MSc, Liping Zhang, Stefan Willmann

Blood (2017) 130 (Supplement 1): 1104.

https://doi.org/10.1182/blood.V130.Suppl_1.1104.1104

Published: 2017

Journal Articles

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

Jung Yoon Choi, MD, Heewon Seo, Yoomi Park, ByungJoo Min, Hyery Kim, MD, Kyung Taek Hong, MD, Che Ry Hong, MD, Sang Hoon Song, MD, Kyung-Sang Yu, MD, In-Jin Jang, MD, Kyung Duk Park, MD, Hee Young Shin, MD, Ju Han Kim, MD, Hyoung Jin Kang, MD

Blood (2017) 130 (Supplement 1): 1963.

https://doi.org/10.1182/blood.V130.Suppl_1.1963.1963

Published: 2017

Journal Articles

The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in the Prevention of Venous Thromboembolism after Elective Hip or Knee Replacement Surgery

Scott D. Berkowitz, MD, Keith A A Fox, MBBS, Stephan Schmidt, Jeffrey I Weitz, MD FRCPC, FACP, Dirk Garmann, Dagmar Kubitza, Wolfgang Mueck, Gary Peters, MD, Isabel Reinecke, Alexander Solms, Theodore E Spiro, MD, Xiaoyu Yan, PhD MSc, Liping Zhang, Stefan Willmann

Blood (2017) 130 (Supplement 1): 3718.

https://doi.org/10.1182/blood.V130.Suppl_1.3718.3718

Published: 2017

Journal Articles

The Cost-Effectiveness of Therapeutic Drug Monitoring (TDM) of Generic Imatinib for the Treatment of Chronic Myelogenous Leukemia

Salvatore Salamone, PhD, Russell Becker, BA, William Padula, PhD, Rena M Conti, PhD

Blood (2017) 130 (Supplement 1): 4701.

https://doi.org/10.1182/blood.V130.Suppl_1.4701.4701

Published: 2017

Journal Articles

Evaluation of an Automated Immunoassay for Quantification of Imatinib in Plasma

Srinivas K. Tantravahi, MBBS, Gwendolyn A. McMillin, PhD, Phillip M. Clair, MS, Aaron J. Sadler, Tracy Dowell, BS, Janice Geier, MT, Philip S. Bernard, MD, Michael W. Deininger, MD PhD

Blood (2017) 130 (Supplement 1): 1626.

https://doi.org/10.1182/blood.V130.Suppl_1.1626.1626

Published: 2017

Journal Articles

Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea

Joana Marie Mack, MD, Pawel Wiczling, PhD, Joseph Moen, MS, Guolian Kang, PhD, Robert I. Liem, MD MS, Julie A. Panepinto, MD MSPH, Gregory Kearns, PharmD, PhD FCP, FAAP, Kathleen A Neville, MD MS, Jeremie H. Estepp, MD

Blood (2016) 128 (22): 1314.

https://doi.org/10.1182/blood.V128.22.1314.1314

Published: 2016

Journal Articles

CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis

Jai N Patel, PharmD, Myra M Robinson, Issam Hamadeh, PharmD, Zainab Shahid, MD, James T Symanowski, PhD, Dragos Plesca, PharmD, PhD, Margaret Croom, PharmD, Jigar Trivedi, MSc, PharmD, Nury M. Steuerwald, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP

Blood (2016) 128 (22): 3416.

https://doi.org/10.1182/blood.V128.22.3416.3416

Published: 2016

Journal Articles

Individualized Dosing of Hydroxyurea for Children with Sickle Cell Anemia Using a Population Pharmacokinetic-Based Model: The TREAT Study

Patrick T. McGann, MD MS, Min Dong, PhD, Anu Marahatta, PhD, Thad A. Howard, MS, Tomoyuki Mizuno, PhD, Karen A. Kalinyak, MD, Theodosia A. Kalfa, MD PhD, Punam Malik, MD, Omar Niss, MD, Charles T Quinn, MD, Russell E. Ware, MD PhD, Alexander A. Vinks, PharmD, PhD

Blood (2016) 128 (22): 3652.

https://doi.org/10.1182/blood.V128.22.3652.3652

Published: 2016

Journal Articles

Therapeutic Drug Monitoring of Posaconazole in Adult Acute Myeloid Leukemia (Aml) Patients Receiving Posaconazole Prophylaxis during Induction: Experience from a Center with High Invasive Fungal Infection (IFI)Burden

Manju Sengar, Sanyo Dsouza, Raviraj Deshpande, Hasmukh Jain, Murari Gurjar, Sadhana Kannan, Nayana Morajkar, Vikram Gota

Blood (2016) 128 (22): 4005.

https://doi.org/10.1182/blood.V128.22.4005.4005

Published: 2016

Journal Articles

Pharmacokinetics, Safety, and Target Attainment of Single and Multiple Doses of CD101 IV

Taylor Sandison, MD MPH, Voon Ong, PhD, Dirk Thye, MD

Blood (2016) 128 (22): 2197.

https://doi.org/10.1182/blood.V128.22.2197.2197

Published: 2016

NARROW

Management of Delayed Elimination of High-Dose Methotrexate in Community Oncology Practices Can Mitigate Its Effect on Length of Hospital Stay, Treatment Dose-Density, Acute Kidney Injury, Dialysis, and Death

Single Arm, Single Centre Prospective Study to Assess the Effect of Therapeutic Drug Monitoring (TDM) Based Dosage Adjustment of Posaconazole on the Incidence of Invasive Fungal Infections (IFIs) in AML Patients on Induction Chemotherapy on Posaconazole Prophylaxis

Pharmacokinetic and Pharmacogenetic Analysis of Bosutinib in Japanese Patients with Chronic-Phase Chronic Myeloid Leukemia

Pharmacist Interventions on Outpatient Leukemia Patients Improve Safety

Drug Monitoring of Asparaginase Activity to Detect Silent Inactivation in Pediatric Acute Lymphoblastic Leukemia Patients Receiving Peg-Asparaginase

Cost-Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Patients with Chronic Myeloid Leukemia

Interest of Dosing of Ibrutinib in B-Cell Lymphoid Malignancies: Data from a Real-Life, Phase 4 Study

Isavuconazole (ISAV) As Primary Anti-Fungal Prophylaxis in Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective Study

Impact of a Pharmacist Driven Anti-Xa Level Monitoring Protocol on Therapeutic Drug Monitoring Practice Patterns

Outcomes of Patients with Pre-Existing Invasive Fungal Disease Undergoing Allogeneic Haematopoietic Stem Cell Transplantation — 5 Years Single Centre Experience

The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients Treated for Venous Thromboembolism

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in the Prevention of Venous Thromboembolism after Elective Hip or Knee Replacement Surgery

The Cost-Effectiveness of Therapeutic Drug Monitoring (TDM) of Generic Imatinib for the Treatment of Chronic Myelogenous Leukemia

Evaluation of an Automated Immunoassay for Quantification of Imatinib in Plasma

Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea

CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis

Individualized Dosing of Hydroxyurea for Children with Sickle Cell Anemia Using a Population Pharmacokinetic-Based Model: The TREAT Study

Therapeutic Drug Monitoring of Posaconazole in Adult Acute Myeloid Leukemia (Aml) Patients Receiving Posaconazole Prophylaxis during Induction: Experience from a Center with High Invasive Fungal Infection (IFI)Burden

Pharmacokinetics, Safety, and Target Attainment of Single and Multiple Doses of CD101 IV

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only